Episode
IV Iron Risks and Low-Dose AML Gains
- Podcast
- Blood Podcast
- Published
- Jul 2, 2026
- Duration seconds
- 1488
- Processing state
not_requested- Canonical source
- https://share.transistor.fm/s/c7970701
Actions
POST https://stenobird.com/v1/public/podcasts/blood-podcast-664776/episodes/iv-iron-risks-and-low-dose-aml-gains/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/blood-podcast-664776/iv-iron-risks-and-low-dose-aml-gains.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this week's episode, Blood editor Dr. James Griffin interviews Drs. Heinz Zoller and Raul Ribeiro on their latest articles published in Blood . Dr. Zoller discusses " Ferric Carboxymaltose Increases Fracture Risk in Patients and Reduces Bone Formation in Mice with Iron Deficiency Anemia ", and how these findings support consideration of alternative IV iron formulations that provide similar efficacy without risk of skeletal complications. Dr. Ribeiro discusses " A low-versus standard-dose regimen an induction for AML: a multicenter, randomized noninferiority trial " and how the low-dose regimen is associated with fewer toxicities, faster hematologic recovery, and reduced health care costs, suggesting a feasible treatment strategy for resource-limited settings.